Increased Accumulation of α-Synuclein in Inflamed Appendices of Parkinson's Disease Patients
- PMID: 33876851
- DOI: 10.1002/mds.28553
Increased Accumulation of α-Synuclein in Inflamed Appendices of Parkinson's Disease Patients
Abstract
Background: The accumulation of α-synuclein (α-Syn) aggregates that leads to the onset of Parkinson's disease (PD) has been postulated to begin in the gastrointestinal tract. The normal human appendix contains pathogenic forms of α-Syn, and appendectomy has been reported to affect the incidence of PD.
Objective: This study investigated appendix abnormality in patients with PD.
Methods: We assessed appendix morphology in 100 patients with PD and 50 control subjects by multislice spiral computed tomography. We analyzed the clinical characteristics of patients with PD with diseased appendices, which was confirmed in seven patients by histopathological analysis.
Results: Chronic appendicitis-like lesions were detected in 53% of patients with PD, but these were not associated with the duration of motor symptoms. Appendicitis-like lesions, impaired olfaction, and rapid eye movement sleep behavior disorder were risk factors for PD. The following clinical symptoms could be used to identify patients with PD with appendicitis-like lesions: first motor symptoms were bradykinesia/rigidity, onset of motor symptoms in the central axis or left limb, prodromal constipation, high ratio of Unified Parkinson's Disease Rating Scale Part III score to symptom duration, low Montreal Cognitive Assessment score, and high Epworth Sleepiness Scale score. The seven patients with PD who were diagnosed with chronic appendicitis underwent appendectomy, and histopathological analysis revealed structural changes associated with chronic appendicitis and α-Syn aggregation.
Conclusions: These results indicate an association between chronic appendicitis-like lesions and PD, and suggest that α-Syn accumulation in the diseased appendix occurs in PD. © 2021 International Parkinson and Movement Disorder Society.
Keywords: Parkinson's disease; appendicitis; appendix; diagnosis; α-synuclein.
© 2021 International Parkinson and Movement Disorder Society.
Similar articles
-
[Alterations in erythrocytic oligomeric alpha-synuclein in patients with Parkinson's disease and multiple system atrophy].Zhonghua Yi Xue Za Zhi. 2023 Oct 10;103(37):2933-2939. doi: 10.3760/cma.j.cn112137-20230607-00957. Zhonghua Yi Xue Za Zhi. 2023. PMID: 37752052 Chinese.
-
Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.Acta Neuropathol. 2017 Apr;133(4):535-545. doi: 10.1007/s00401-017-1684-z. Epub 2017 Feb 8. Acta Neuropathol. 2017. PMID: 28180961 Free PMC article.
-
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.Mov Disord. 2019 Sep;34(9):1354-1364. doi: 10.1002/mds.27806. Epub 2019 Jul 30. Mov Disord. 2019. PMID: 31361367 Free PMC article.
-
Premotor Diagnosis of Parkinson's Disease.Neurosci Bull. 2017 Oct;33(5):526-534. doi: 10.1007/s12264-017-0159-5. Epub 2017 Aug 3. Neurosci Bull. 2017. PMID: 28776303 Free PMC article. Review.
-
The Appendix in Parkinson's Disease: From Vestigial Remnant to Vital Organ?J Parkinsons Dis. 2019;9(s2):S345-S358. doi: 10.3233/JPD-191703. J Parkinsons Dis. 2019. PMID: 31609697 Free PMC article. Review.
Cited by
-
Gut microbiota, pathogenic proteins and neurodegenerative diseases.Front Microbiol. 2022 Nov 18;13:959856. doi: 10.3389/fmicb.2022.959856. eCollection 2022. Front Microbiol. 2022. PMID: 36466655 Free PMC article. Review.
-
Update to the Treatment of Parkinson's Disease Based on the Gut-Brain Axis Mechanism.Front Neurosci. 2022 Jul 6;16:878239. doi: 10.3389/fnins.2022.878239. eCollection 2022. Front Neurosci. 2022. PMID: 35873830 Free PMC article. Review.
-
The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic.Nat Rev Neurol. 2022 Aug;18(8):476-495. doi: 10.1038/s41582-022-00681-2. Epub 2022 Jun 24. Nat Rev Neurol. 2022. PMID: 35750883 Review.
-
Alpha-synuclein and tau are abundantly expressed in the ENS of the human appendix and monkey cecum.PLoS One. 2022 Jun 10;17(6):e0269190. doi: 10.1371/journal.pone.0269190. eCollection 2022. PLoS One. 2022. PMID: 35687573 Free PMC article.
References
-
- Espay AJ, Brundin P, Lang AE. Precision medicine for disease modification in Parkinson disease. Nat Rev Neurol 2017;13:119-126.
-
- Espay AJ, Schwarzschild MA, Tanner CM, et al. Biomarker-driven phenotyping in Parkinson's disease: a translational missing link in disease-modifying clinical trials. Mov Disord 2017;32:319-324.
-
- Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P. Triggers, facilitators, and aggravators: redefining Parkinson's disease pathogenesis. Trends Neurosci 2019;42:4-13.
-
- Horsager J, Andersen KB, Knudsen K, et al. Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study. Brain 2020;143:3077-3088.
-
- Kaye J, Gage H, Kimber A, Storey L, Trend P. Excess burden of constipation in Parkinson's disease: a pilot study. Mov Disord 2006;21:1270-1273.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous